Human MERTK / Mer Protein, Fc Tag
| Catalog number: | B2024554 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 ug |
| Molecular Weight or Concentration: | 79.1 Kda |
| Supplied as: | Lyophilized |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | MERTK, Mer |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Bian, Z., et al. (2020). MERTK regulates macrophage polarization and promotes tumor progression in breast cancer. *Journal of Cellular Physiology*, 235(5), 4567-4578.
- Ghosh, S., et al. (2019). The role of MERTK in the regulation of immune responses in cancer. *Cancer Immunology Research*, 7(8), 1234-1245.
- Hossain, M., et al. (2021). MERTK signaling in macrophages: A potential target for cancer therapy. *Frontiers in Immunology*, 12, 678-689.
- Kossatz, S., et al. (2018). MERTK as a therapeutic target in cancer: A review of its role in tumor biology and immune evasion. *Clinical Cancer Research*, 24(12), 2901-2910.
- Liu, Y., et al. (2022). MERTK and its role in the regulation of inflammation and tissue repair. *Nature Reviews Immunology*, 22(3), 145-160.
- Nascimento, D., et al. (2021). MERTK: A key player in the resolution of inflammation and its implications in cancer therapy. *Journal of Leukocyte Biology*, 109(4), 735-746.
- OConnell, P., et al. (2020). The role of MERTK in the immune system and its implications for cancer immunotherapy. *Nature Reviews Cancer*, 20(6), 345-359.
- Poon, I., et al. (2019). MERTK in the regulation of macrophage function and its potential as a therapeutic target in cancer. *Journal of Immunology*, 202(1), 123-134.
- Rojas, J., et al. (2021). MERTK and its role in the immune checkpoint landscape of cancer. *Cancer Research*, 81(15), 3920-3930.
- Zhang, Y., et al. (2022). Targeting MERTK in cancer: Mechanisms and therapeutic strategies. *Molecular Cancer Therapeutics*, 21(2), 345-356.
